GB8613320D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number: GB8613320D0
Authority: GB; United Kingdom
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 1985-06-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

GB868613320A

Other versions

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Chugai Pharmaceutical Co Ltd

Original Assignee

Chugai Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-06-04

Filing date

1986-06-02

Publication date

1986-07-09

1986-06-02 Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd

1986-07-09 Publication of GB8613320D0 publication Critical patent/GB8613320D0/en

1987-02-04 Publication of GB2177914A publication Critical patent/GB2177914A/en

1989-10-25 Application granted granted Critical

1989-10-25 Publication of GB2177914B publication Critical patent/GB2177914B/en

Status Expired legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Otolaryngology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GB8613320A 1985-06-04 1986-06-02 A pharmaceutical composition containing human erythropoietin and a surface active agent for nasal administration for the treatment of anemia Expired GB2177914B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP12112685		1985-06-04

Publications (3)

Publication Number	Publication Date
GB8613320D0 true GB8613320D0 (en)	1986-07-09
GB2177914A GB2177914A (en)	1987-02-04
GB2177914B GB2177914B (en)	1989-10-25

Family

ID=14803522

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB8613320A Expired GB2177914B (en)	1985-06-04	1986-06-02	A pharmaceutical composition containing human erythropoietin and a surface active agent for nasal administration for the treatment of anemia

Country Status (4)

Country	Link
JP (1)	JPH0676336B2 (en)
DE (1)	DE3618561A1 (en)
FR (1)	FR2587216B1 (en)
GB (1)	GB2177914B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3601923A1 (en) *	1986-01-23	1987-07-30	Behringwerke Ag	NASAL APPLICABLE MEDICINE, METHOD FOR THE PRODUCTION AND USE THEREOF
JP2858752B2 (en) *	1987-04-10	1999-02-17	オーソ・フアーマシユーチカル・コーポレーシヨン	Methods for increasing hematocrit in normal mammals
JP3249147B2 (en) *	1990-06-01	2002-01-21	キリン−アムジエン・インコーポレーテツド	Oral preparation containing bioactive protein
EP0459516A1 (en) *	1990-06-01	1991-12-04	Kirin-Amgen, Inc.	Oral dosage form of biologically active proteins
RU2158269C2 (en) *	1991-02-08	2000-10-27	Про-Ньюрон, Инк.	Acyl derivatives of guanosine, inosine, xanthosine, deoxy-inosine, deoxyguanosine, inosine-2',3'-(acyclic)-dialcohol or their pharmaceutically acceptable salts, hemopoiesis-stimulating pharmaceutical composition, method of treatment of cytopenia
DE4126983A1 (en) *	1991-08-15	1993-02-18	Boehringer Mannheim Gmbh	METHOD FOR THE PRODUCTION OF HUMAN-PROTEIN-CONTAINING, PRESERVED MEDICAMENTS FOR INFUSION OR INJECTION USE
DE4126984A1 (en) *	1991-08-15	1993-02-18	Boehringer Mannheim Gmbh	PROCESS FOR THE MANUFACTURE OF HUMAN PROTEIN-CONTAINING, SUITABLE MEDICAMENTS FOR INFUSION OR INJECTION USE
US5354934A (en) *	1993-02-04	1994-10-11	Amgen Inc.	Pulmonary administration of erythropoietin
GB9506051D0 (en) *	1995-03-24	1995-05-10	Univ Singapore	Gene expression
WO2004084859A2 (en)	2003-03-21	2004-10-07	Nastech Pharmaceutical Company Inc.	Nasal calcitonin formulations containing chlorobutanol
CU23317A1 (en) *	2005-07-22	2008-10-22	Ct De Investigacia N Y Desarro	NASAL EPORH FORMULATIONS WITH LOW SYLICAL ACID CONTENT FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES
JP5809057B2 (en) *	2009-09-15	2015-11-10	株式会社カネカ	Modified erythropoietin with a water-soluble long-chain molecule
JP5672554B2 (en) *	2010-08-19	2015-02-18	Ｊｃｒファーマ株式会社	Composition for subcutaneous or transdermal absorption

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1527605A (en) *	1975-08-20	1978-10-04	Takeda Chemical Industries Ltd	Insulin preparation for intranasal administration
JPS6045849B2 (en) *	1980-08-25	1985-10-12	林原健	Method for producing human erythropoietin
JPS57149228A (en) *	1981-03-11	1982-09-14	Ajinomoto Co Inc	Novel erythropoietin and its preparation
IL70489A0 (en) *	1982-12-29	1984-03-30	Armour Pharma	Pharmaceutical compositions containing calcitonin
JPH0686480B2 (en) *	1983-02-21	1994-11-02	雪印乳業株式会社	Monoclonal antibody for erythropoietin production
NZ210501A (en) *	1983-12-13	1991-08-27	Kirin Amgen Inc	Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
JPS6197229A (en) *	1984-10-18	1986-05-15	Chugai Pharmaceut Co Ltd	Stable erythropoietin preparation
JPS61126014A (en) *	1984-11-22	1986-06-13	Teijin Ltd	Aqueous liquid drug for transnasal administration
US4745099A (en) *	1985-02-06	1988-05-17	Chugai Seiyaku Kabushiki Kaisha	Pharmaceutical composition for the treatment of the anemia of malignant tumors
US4732889A (en) *	1985-02-06	1988-03-22	Chugai Seiyaku Kabushiki Kaisha	Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis

1986
- 1986-06-02 GB GB8613320A patent/GB2177914B/en not_active Expired
- 1986-06-03 DE DE19863618561 patent/DE3618561A1/en not_active Withdrawn
- 1986-06-03 JP JP61129470A patent/JPH0676336B2/en not_active Expired - Lifetime
- 1986-06-03 FR FR8607946A patent/FR2587216B1/en not_active Expired

Also Published As

Publication number	Publication date
FR2587216A1 (en)	1987-03-20
JPS6289627A (en)	1987-04-24
DE3618561A1 (en)	1987-01-02
FR2587216B1 (en)	1989-09-22
GB2177914A (en)	1987-02-04
GB2177914B (en)	1989-10-25
JPH0676336B2 (en)	1994-09-28

Publication	Publication Date	Title
GR862464B (en)	1987-02-02	Pharmaceutical composition
GB8602787D0 (en)	1986-03-12	Pharmaceutical composition
GB8602788D0 (en)	1986-03-12	Pharmaceutical composition
GB2174904B (en)	1989-07-05	Vasculoprotecting pharmaceutical compositions
GB8530796D0 (en)	1986-01-22	Pharmaceutical composition
GB2171600B (en)	1988-08-10	Pharmaceutical compositions
GB8602625D0 (en)	1986-03-12	Pharmaceutical compositions
GB8607906D0 (en)	1986-05-08	Pharmaceutical compositions
GB8613320D0 (en)	1986-07-09	Pharmaceutical composition
GB8515170D0 (en)	1985-07-17	Pharmaceutical compositions
GB8602602D0 (en)	1986-03-12	Pharmaceutical compositions
GB8607848D0 (en)	1986-04-30	Pharmaceutical compositions
GB2182561B (en)	1989-12-06	Pharmaceutical compositions
GB8523531D0 (en)	1985-10-30	Pharmaceutical compositions
GB8522327D0 (en)	1985-10-16	Pharmaceutical compositions
GB8602601D0 (en)	1986-03-12	Pharmaceutical compositions
GB8608309D0 (en)	1986-05-08	Pharmaceutical compositions
GB8502887D0 (en)	1985-03-06	Pharmaceutical compositions
GB8608310D0 (en)	1986-05-08	Pharmaceutical compositions
ZA86379B (en)	1986-10-29	Pharmaceutical composition
IE851996L (en)	1986-02-16	Pharmaceutical composition
IE851361L (en)	1985-12-04	Pharmaceutical composition
IE850837L (en)	1985-10-03	Pharmaceutical composition
GB8521251D0 (en)	1985-10-02	Pharmaceutical composition
GB8521252D0 (en)	1985-10-02	Pharmaceutical composition

Legal Events

Date	Code	Title	Description
1994-01-26	PCNP	Patent ceased through non-payment of renewal fee	Effective date: 19930602